NCT01604512 2025-04-08
A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression
Memorial Sloan Kettering Cancer Center
Phase NA Completed
Clinical Trials
6 trialsNCT04332419 2022-06-22
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies
Case Comprehensive Cancer Center
Phase NA Completed
NCT02286843 2021-06-18
Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01892540 2020-03-04
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT02410577 2019-03-19
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02202317 2017-12-29
Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors
University of Miami
Phase NA Completed